Degenerative Mitral Stenosis: From Pathophysiology to Challenging Interventional Treatment

Area of Science:

• Cardiology
• Interventional Cardiology
• Valvular Heart Disease

Background:

• Mitral stenosis (MS) obstructs left ventricular inflow, causing significant morbidity and mortality.
• While postrheumatic disease is the global cause, degenerative changes are increasingly prevalent in developed nations.
• Therapeutic advancements for mitral valve disease lag behind aortic valve disease due to complex anatomy and device challenges.

Purpose of the Study:

• To review the current landscape of mitral stenosis treatment.
• To highlight challenges in developing transcatheter mitral valve devices.
• To explore recent innovations in interventional procedures for degenerative mitral stenosis.

Main Methods:

• Review of current literature on mitral stenosis etiology and treatment.
• Analysis of challenges in transcatheter mitral valve interventions.
• Discussion of emerging transcatheter technologies for degenerative mitral stenosis.

Main Results:

• Degenerative mitral stenosis is common in developed countries, often lacking commissural fusion, making traditional interventions difficult.
• Transcatheter mitral valve replacement faces anatomical complexities, hindering device development.
• Recent innovations show promise for transcatheter interventions in degenerative mitral stenosis.

Conclusions:

• Transcatheter mitral valve replacement may become the preferred treatment for degenerative mitral stenosis.
• Continued innovation is crucial to overcome anatomical challenges for mitral valve interventions.
• Improved transcatheter therapies could significantly impact the management of mitral stenosis.